Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
ly4101174 Urinary Bladder Neoplasm	Eli Lilly and Company	P1	CC (43)
ly4152199 - iv Marginal Zone Lymphoma	Eli Lilly and Company	P1	CC (43)
ly4152199 - iv Follicular Lymphoma	Eli Lilly and Company	P1	CC (43)
ly4152199 - iv Mantle Cell Lymphoma	Eli Lilly and Company	P1	CC (43)
ly4170156 Triple-Negative Breast Carcinoma	Eli Lilly and Company	P1	CC (43)
ly4257496 Esophageal Cancer	Eli Lilly and Company	P1	CC (43)
ly4257496 Prostate Neoplasm	Eli Lilly and Company	P1	CC (43)
ly4337713 Esophageal Cancer	Eli Lilly and Company	P1	CC (43)
ly4584180 Diffuse Large B-Cell Lymphoma	Eli Lilly and Company	P1	CC (43)
ly4584180 Non-Hodgkin Lymphoma	Eli Lilly and Company	P1	CC (43)
lyl797 Endometrioid Tumor	Lyell Immunopharma, Inc.	P1	CC (43)
lyl797 Ovarian Serous Adenocarcinoma	Lyell Immunopharma, Inc.	P1	CC (43)
lyl797 Ovarian Carcinoma	Lyell Immunopharma, Inc.	P1	CC (43)
m28z1xxpd1dnr car Gastroesophageal Adenocarcinoma	Memorial Sloan Kettering Cancer Center	P1	CC (43)
m28z1xxpd1dnr car Neoplasm	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Mabel Ctls Hodgkins Lymphoma	Baylor College of Medicine	P1	CC (43)
Mabel Ctls Nasopharyngeal Carcinoma	Baylor College of Medicine	P1	CC (43)
Mabel Ctls Non-Hodgkin Lymphoma	Baylor College of Medicine	P1	CC (43)
Mabel Ctls Immunodeficiency 32B	Baylor College of Medicine	P1	CC (43)
Mabel Ctls Smooth Muscle Tumor	Baylor College of Medicine	P1	CC (43)
Mabel Ctls T-Cell And NK-Cell Neoplasm	Baylor College of Medicine	P1	CC (43)
Magicell-Nk Contains Nk Cells Suspended In Normal Saline Colorectal Cancer	Medigen Biotechnology Corporation	P1	CC (43)
Mangafodipir Epilepsy	National Institute of Neurological Disorders and Stroke (NINDS)	P1	CC (43)
Maprotiline Brain Neoplasm	University of Rochester	P1	CC (43)
Maprotiline Glioblastoma	University of Rochester	P1	CC (43)

Showing 3226 to 3250 of 9,920 assets

PreviousPage 130 of 397Next